派博傳思國(guó)際中心

標(biāo)題: Titlebook: Leptomeningeal Metastases; Lauren E. Abrey,Marc C. Chamberlain,Herbert H. Eng Book 2005 Springer-Verlag US 2005 Nervous System.anatomy.can [打印本頁(yè)]

作者: sprawl    時(shí)間: 2025-3-21 17:53
書(shū)目名稱(chēng)Leptomeningeal Metastases影響因子(影響力)




書(shū)目名稱(chēng)Leptomeningeal Metastases影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Leptomeningeal Metastases網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Leptomeningeal Metastases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Leptomeningeal Metastases被引頻次




書(shū)目名稱(chēng)Leptomeningeal Metastases被引頻次學(xué)科排名




書(shū)目名稱(chēng)Leptomeningeal Metastases年度引用




書(shū)目名稱(chēng)Leptomeningeal Metastases年度引用學(xué)科排名




書(shū)目名稱(chēng)Leptomeningeal Metastases讀者反饋




書(shū)目名稱(chēng)Leptomeningeal Metastases讀者反饋學(xué)科排名





作者: Corral    時(shí)間: 2025-3-21 21:57
Neil Barshes MD,Alexis Demopoulos MD,Herbert H. Engelhard MD, PhDhe company’s business model, the competitive environment and strategy, the integrated risk management model, and the corporate governance system. The review of the report continues with a brief illustration of the section regarding the Consolidated Sustainability Statement. In particular, sustainabi
作者: uncertain    時(shí)間: 2025-3-22 00:55

作者: 間諜活動(dòng)    時(shí)間: 2025-3-22 07:11

作者: 遭遇    時(shí)間: 2025-3-22 12:31
Craig P. Nolan M.D.,Lauren E. Abrey M.D. firms quoted on the Warsaw Stock Exchange to currently adopt integrated reporting approach in their disclosure policy. We identify their organizational and sectorial characteristics, disclosure dynamics and evolution as well as the practice of integrated reporting. More specifically, using the IIRC
作者: 郊外    時(shí)間: 2025-3-22 13:53

作者: ESO    時(shí)間: 2025-3-22 18:29
Kathleen A. Neville M.D,Susan M. Blaney M.D organisation, the discussion proceeds to the integrated reporting journey of DIMO, the organisation’s thinking behind IR and its adaptation, integrated thinking and materiality at DIMO. A brief discussion on the DIMO Annual Report brings the chapter to a close.
作者: ALIBI    時(shí)間: 2025-3-23 01:04

作者: NUL    時(shí)間: 2025-3-23 05:28

作者: exclusice    時(shí)間: 2025-3-23 08:49

作者: commute    時(shí)間: 2025-3-23 13:03
Ali Raja M.D.,Herbert H. Engelhard M.D., Ph.D.l crisis. The Chapter ends with a new proposal for measuring audit risk; in particular, audit risk could be measured from a qualitative and quantitative point of view. Qualitative features of the audit risk model are related to the corporate governance system in place within the firm and the quality
作者: Middle-Ear    時(shí)間: 2025-3-23 16:28
Kurt A. Jaeckle M.D.ückschauen, aber nur sp?rlich nach vorn. Der Aufsichtsratsvorsitzende der Deutschen Bank, Paul Achleitner, verglich den Wettbewerb ?Der beste Gesch?ftsbericht“, dessen Jury ich zwanzig Jahre angeh?rte, deshalb einmal mit einer Oldtimer-Rally. Eines wurde und wird in Gesch?ftsberichten nur sehr selte
作者: 影響帶來(lái)    時(shí)間: 2025-3-23 19:04

作者: conservative    時(shí)間: 2025-3-23 23:39

作者: macabre    時(shí)間: 2025-3-24 04:44
Cancer Treatment and Researchhttp://image.papertrans.cn/l/image/585003.jpg
作者: Directed    時(shí)間: 2025-3-24 08:35
Book 2005.Leptomeningeal Metastases. is intended to provide the reader with an overview of the state-of-the-art therapy for the cancer patient with leptomeningeal cancer with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies.
作者: 在駕駛    時(shí)間: 2025-3-24 10:40
https://doi.org/10.1007/b104814Nervous System; anatomy; cancer; carcinoma; central nervous system; clinical trial; imaging; leukemia; lymph
作者: BET    時(shí)間: 2025-3-24 16:31
Animal Models of Leptomeningeal Cancer,Animal models are a critical tool for our understanding of pathogenic mechanisms and the development of therapeutic strategies. Since the 1970‘s, numerous syngeneic and allogeneic rodent models of leptomeningeal cancer have been developed; in this chapter, we present representative models and discuss their clinical and translational implications.
作者: Bricklayer    時(shí)間: 2025-3-24 22:28

作者: abject    時(shí)間: 2025-3-24 23:29
Leptomeningeal Metastases978-0-387-24199-9Series ISSN 0927-3042 Series E-ISSN 2509-8497
作者: 等級(jí)的上升    時(shí)間: 2025-3-25 04:04
Anatomy and Physiology of the Leptomeninges and CSF Space, system by cells of the choroid plexus and ependyma. This chapter describes in detail the normal anatomic structure and physiologic interactions of the cerebrospinal fluid and leptomeningeal space that are critical to our understanding and treatment of leptomeningeal metastases.
作者: neolith    時(shí)間: 2025-3-25 08:14
Leptomeningeal Metastasis of Primary Central Nervous System (CNS) Neoplasms,cell tumors, and primary CNS lymphoma, seeding of the cerebrospinal fluid space is a critical factor in determining stage, prognosis and appropriate therapy. Other tumor types, such as glioma, may have radiographic evidence of leptomeningeal metastases without clear impact on prognosis or therapy.
作者: Adjourn    時(shí)間: 2025-3-25 12:19
Leptomeningeal Cancer in the Pediatric Patient,wever, the treatment of other leptomeningeal cancers has been less successful and the neurologic morbidity associated with central nervous system-directed therapy has a significant long-term impact on quality of life. Further research is critical to identify new therapeutic strategies for children with or at high risk for leptomeningeal cancer.
作者: 擁護(hù)    時(shí)間: 2025-3-25 18:12
Current Treatment of Leptomeningeal Metastases: Systemic Chemotherapy, Intrathecal Chemotherapy andhe majority of patients have widespread incurable systemic tumor, treatment is predominantly palliative; however, some patients with leukemia, lymphoma or breast cancer may have prolonged remissions and the possibility of cure.
作者: inscribe    時(shí)間: 2025-3-25 20:17
Improving the Outcome of Patients with Leptomeningeal Cancer: New Clinical Trials and Experimental are being developed to target the cerebrospinal space. These include new intrathecal formulations of systemic chemotherapy as well as the development of radiolabeled immunoconjugates and antitumor antibodies. Furthermore, there is debate as to the optimal strategy of drug delivery for leptomeningeal tumor.
作者: Dendritic-Cells    時(shí)間: 2025-3-26 00:27
Leptomeningeal Metastases from Solid Tumors (Meningeal Carcinomatosis),n limited. Radiotherapy is used to treat bulky tumor and provide symptomatic relief. Intrathecal chemotherapy benefits a selected subset of patients. The challenge to the future is to delineate the molecular mechanisms underlying LM and to develop novel therapeutic or prophylactic modalities to combat LM.
作者: 自愛(ài)    時(shí)間: 2025-3-26 07:27
Leptomeningeal Metastases from Leukemias and Lymphomas, crucial and prophylactic therapy of the CSF compartment is required. Furthermore, while the overall prognosis for patients with leptomeningeal metastases from leukemia and lymphoma is similar to solid tumors, selected patients have excellent response to therapy and attain durable remission. Therefore, aggressive treatment is warranted.
作者: 煞費(fèi)苦心    時(shí)間: 2025-3-26 12:30
Neurosurgical Interventions for Leptomeningeal Tumor,will be presented. The aim will be to familiarize non-surgical providers with the indications for and complications associated with these neurosurgical procedures as a component of the adjuvant treatment of leptomeningeal disease.
作者: Prognosis    時(shí)間: 2025-3-26 13:18
0927-3042 e-of-the-art therapy for the cancer patient with leptomeningeal cancer with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies.978-1-4614-9890-2978-0-387-24199-9Series ISSN 0927-3042 Series E-ISSN 2509-8497
作者: 別名    時(shí)間: 2025-3-26 19:27
Leptomeningeal Neoplasia: Epidemiology, Clinical Presentation, CSF Analysis and Diagnostic Imaging,ystem prophylaxis. Regardless, both types of patients present with symptoms referrable to multiple levels of the central nervous system and a careful dignostic approach incorporating cerebrospinal fluid studies and appropriate neuroimaging is critical.
作者: ferment    時(shí)間: 2025-3-27 00:35

作者: hedonic    時(shí)間: 2025-3-27 02:27
0927-3042 new clinical trials, epidemiology, as well as research in a.Leptomeningeal Metastases. is intended to provide the reader with an overview of the state-of-the-art therapy for the cancer patient with leptomeningeal cancer with additional information on epidemiology, symptom management, new clinical t
作者: 你敢命令    時(shí)間: 2025-3-27 08:43

作者: 和音    時(shí)間: 2025-3-27 09:47

作者: flimsy    時(shí)間: 2025-3-27 15:51
Leptomeningeal Metastases from Solid Tumors (Meningeal Carcinomatosis), advances in diagnostic imaging have led to an apparent increase in the number of patients diagnosed with LM. Unfortunately, therapeutic options remain limited. Radiotherapy is used to treat bulky tumor and provide symptomatic relief. Intrathecal chemotherapy benefits a selected subset of patients.
作者: 整理    時(shí)間: 2025-3-27 18:17

作者: voluble    時(shí)間: 2025-3-28 01:49

作者: 獨(dú)白    時(shí)間: 2025-3-28 03:27

作者: 煤渣    時(shí)間: 2025-3-28 07:59

作者: patriot    時(shí)間: 2025-3-28 13:23
Current Treatment of Leptomeningeal Metastases: Systemic Chemotherapy, Intrathecal Chemotherapy andhe majority of patients have widespread incurable systemic tumor, treatment is predominantly palliative; however, some patients with leukemia, lymphoma or breast cancer may have prolonged remissions and the possibility of cure.
作者: 射手座    時(shí)間: 2025-3-28 15:53

作者: CANDY    時(shí)間: 2025-3-28 18:57

作者: Collar    時(shí)間: 2025-3-29 02:27
to the social, environmental, economic and ethical responsibilities these managers and their corporation feel they have towards stakeholders. Engagement and dialogue initiatives, therefore, are increasingly recognised as crucial elements of this accountability process. Only through stakeholder enga
作者: 抱怨    時(shí)間: 2025-3-29 05:18
Neil Barshes MD,Alexis Demopoulos MD,Herbert H. Engelhard MD, PhDnd gas value chain from the upstream phase of hydrocarbon exploration to the downstream phase of product marketing. The purpose is to shed light on Eni’s recent advances in corporate reporting. Therefore, after having briefly illustrated Eni’s distinctive approach to sustainable value creation, the
作者: 密切關(guān)系    時(shí)間: 2025-3-29 08:06

作者: 節(jié)約    時(shí)間: 2025-3-29 13:23

作者: 相信    時(shí)間: 2025-3-29 17:41

作者: Habituate    時(shí)間: 2025-3-29 20:22

作者: Substance-Abuse    時(shí)間: 2025-3-30 01:08
Kathleen A. Neville M.D,Susan M. Blaney M.Due for providers of financial capital in the short, medium and long terms. As a result, IR has encouraged organisations to prepare integrated reports and institutionalise trade-offs related to decision making on resource allocation. The universal adoption of IR is gathering momentum, and the case fo
作者: inconceivable    時(shí)間: 2025-3-30 08:04
Jeffrey P. Greenfield,Mark H. Bilskynka and explores the potential to extend these practices to control corporate crises in order to facilitate sustainability and integrated reporting. Secondary research was conducted to examine the control and surveillance practices undertaken by the public sector in mitigating the spread of the nove
作者: 昏睡中    時(shí)間: 2025-3-30 11:24
Stacey L. Berg M.D.,Marc C. Chamberlain M.D.ne of the regional plantations Companies in Sri Lanka. It provides a business case analysis of the evolution of sustainability practices and the corporate reporting mechanism in TTE PLC. More specifically, this case presents the evolution of the sustainability practices and reporting mechanism of th




歡迎光臨 派博傳思國(guó)際中心 (http://www.pjsxioz.cn/) Powered by Discuz! X3.5
高青县| 长春市| 奎屯市| 芦山县| 肇庆市| 武城县| 萨迦县| 旺苍县| 渝北区| 布拖县| 理塘县| 裕民县| 马尔康县| 信丰县| 广饶县| 兴安盟| 金阳县| 惠安县| 兴仁县| 察哈| 永仁县| 赤城县| 喀喇沁旗| 莱阳市| 辉南县| 宽甸| 郴州市| 九江市| 元氏县| 三穗县| 德清县| 美姑县| 湟中县| 上栗县| 庆云县| 商水县| 会理县| 吴川市| 梁平县| 日喀则市| 尚志市|